BLOG

Medical device companies rarely sell the same way twice. A single capital asset can move under a purchase order, a lease, a hybrid usage fee, or a fin...

How medical device companies configure NetSuite for UDI compliance, 21 CFR Part 820 quality system requirements, and service contract revenue under AS...

How management services organizations configure NetSuite for management fee accounting, intercompany billing across physician practices, and multi-ent...

How radiopharmaceutical operators configure NetSuite for decay-adjusted inventory, NRC compliance, and activity-based cost accounting on short half-li...

How small molecule pharma companies configure NetSuite for milestone accounting, royalty tracking, ASC 606 and ASC 808 collaboration agreements.

How specialty pharmacies configure NetSuite for gross-to-net revenue recognition, 340B program compliance, and DSCSA serialization and traceability.

How behavioral health and substance use disorder treatment organizations configure NetSuite for payer contract management, multi-site consolidation, a...

How biologics companies configure NetSuite to support the IND to BLA transition, biosimilar launch economics, and 21 CFR Part 11 compliance.

How contract development and manufacturing organizations configure NetSuite for project accounting, GMP compliance, and multi-entity consolidation acr...

How cell and gene therapy companies configure NetSuite for patient-level lot tracking, small batch cost accounting, and the IND to BLA transition.

How compounding pharmacies configure NetSuite for 503A and 503B operations, USP 795 and 797 compliance, beyond-use dating, and FDA registered outsourc...

How dental service organizations configure NetSuite for multi-location accounting, acquisition integration, de novo practice tracking, and DSO consoli...

In every ERP evaluation cycle, I hear a familiar theme. Newer platforms promise faster deployments, cleaner architecture, and AI native intelligence....

In an era where the life sciences and biotechnology sectors are poised for unprecedented growth, the intricacies of navigating pharmaceutical complian...

Pennsylvania is quickly emerging as a national leader in the life sciences sector. From major convention floors in Boston to local biotech labs in Mal...

The world of Healthcare & Life Sciences (HLS) is rapidly embracing Artificial Intelligence, transforming every stage of drug development, from the ini...

It’s that time of year again—not for holiday shopping, but for preparing your HCP aggregate spend data . The Open Payments (Sunshine Act) reporting wi...

In the pharmaceutical industry, accurately calculating revenue from drug sales is essential for financial reporting, pricing strategy, and regulatory...